Literature DB >> 9890621

The detection of Shiga toxins in the kidney of a patient with hemolytic uremic syndrome.

H Uchida1, N Kiyokawa, H Horie, J Fujimoto, T Takeda.   

Abstract

Infection of Shiga toxin (Stx)-producing Escherichia coli induces hemolytic uremic syndrome (HUS) in 10 to 15% of cases in infants and young children. Although the endothelial cell damage induced by Stx is widely believed to be a primary event of renal dysfunction in HUS, the precise mechanism remains to be elucidated. We were able to examine the kidney obtained at autopsy of a child who died after HUS associated with Stx-producing Escherichia coli O157:H7 infection, and immunohistochemistry indicated the deposition of Stxl and Stx2 in a portion of the distal tubular epithelia. To our knowledge, this is the first report to show the presence of Stx in human tissue of a patient with HUS, and the results obtained in this study provide evidence that Stx indeed migrates into the kidney and binds to renal tubules during Stx-producing Escherichia coli infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9890621     DOI: 10.1203/00006450-199901000-00022

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  15 in total

Review 1.  Entry of ricin and Shiga toxin into cells: molecular mechanisms and medical perspectives.

Authors:  K Sandvig; B van Deurs
Journal:  EMBO J       Date:  2000-11-15       Impact factor: 11.598

Review 2.  Shiga toxin pathogenesis: kidney complications and renal failure.

Authors:  Tom G Obrig; Diana Karpman
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

3.  Differential response of the human renal proximal tubular epithelial cell line HK-2 to Shiga toxin types 1 and 2.

Authors:  Erin K Lentz; Dinorah Leyva-Illades; Moo-Seung Lee; Rama P Cherla; Vernon L Tesh
Journal:  Infect Immun       Date:  2011-06-27       Impact factor: 3.441

4.  Monoclonal antibody to Shiga toxin 2 which blocks receptor binding and neutralizes cytotoxicity.

Authors:  H Nakao; N Kiyokawa; J Fujimoto; S Yamasaki; T Takeda
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

5.  Hemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers.

Authors:  Leticia H Nolasco; Nancy A Turner; Aubrey Bernardo; Zhenyin Tao; Thomas G Cleary; Jing-Fei Dong; Joel L Moake
Journal:  Blood       Date:  2005-08-30       Impact factor: 22.113

6.  Examination of recovery in vitro and in vivo of nonculturable Escherichia coli O157:H7.

Authors:  G L Kolling; K R Matthews
Journal:  Appl Environ Microbiol       Date:  2001-09       Impact factor: 4.792

Review 7.  Shiga Toxin (Stx) Classification, Structure, and Function.

Authors:  Angela R Melton-Celsa
Journal:  Microbiol Spectr       Date:  2014-08

Review 8.  Renal and neurological involvement in typical Shiga toxin-associated HUS.

Authors:  Howard Trachtman; Catherine Austin; Maria Lewinski; Rolf A K Stahl
Journal:  Nat Rev Nephrol       Date:  2012-09-18       Impact factor: 28.314

9.  Host protein binding and adhesive properties of H6 and H7 flagella of attaching and effacing Escherichia coli.

Authors:  Aysen L Erdem; Fabiola Avelino; Juan Xicohtencatl-Cortes; Jorge A Girón
Journal:  J Bacteriol       Date:  2007-08-10       Impact factor: 3.490

10.  Down-regulation of platelet surface CD47 expression in Escherichia coli O157:H7 infection-induced thrombocytopenia.

Authors:  Ya-Lan Guo; Dan-Qing Liu; Zhen Bian; Chen-Yu Zhang; Ke Zen
Journal:  PLoS One       Date:  2009-09-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.